new glp-1 drug retatrutide Unapproved weight loss causes extreme side effects Retatrutide vs Semaglutide and Tirzepatide:
Description
Diabetologia (2010) 53(1):1539
This glucose dependent mechanism means they lower blood sugar primarily when its elevated reducing hypoglycemia risk compared with older diabetes medications
Use of GLP-1 receptor agonists and subsequent risk of alcohol-related events
As a result, these drugs can help lower blood sugar and support weight loss
GLP-1 receptor agonists mimic gut hormones to curb appetite and slow digestion, a mechanism driving the success of therapies from Novo Nordisk (Ozempic for diabetes and Wegovy for weight loss) and Lilly (Mounjaro for diabetes and Zepbound for weight loss)
Harkavyi A, Rampersaud N, Whitton PS
